Finnish Scientists Discover New Approach To Treat Virus-induced Lymphomas

Paramecium submitted, created time 1 year 9 months (www.sciencedaily.com)

Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis. Researchers at the University of Helsinki have discovered that activation of the p53 pathway offers a novel effective treatment modality for KSHV-infected lymphomas.

Submit comment | Blog It | Email It | Keywords: Virus-induced lymphomas Kaposis sarcoma herpesvirus primary effusion lymphoma